Chul Oncologie Oncologie Pédiatrique Chul Pédiatrique Oncologie Pédiatrique Chul marialyzuroshi Rabu, 04 April 2018 Pd1 blockade with nivolumab in relapsed or refractory. Backgroundpreclinical studies advocate that reedsternberg cells take advantage of the...